“a nonsignificant trend”

We also observed a nonsignificant trend toward lower OCT use over IVUS with increasing operator age (OR = 0.93, 95% CI 0.73-1.00, P = 0.06; Supplemental Table S3 ).

0.45±0.03 or control, Mann Whitney U, p<0.0001), and a nonsignificant trend towards higher PPAR γ gene expression (0.58±0.10 for PAH vs. 0.47±0.11 for control, p = 0.06), and lower PPAR γ methylation (36.4±6.3% for PAH vs. 37.8±14.9% for control, p = 0.07, Mann Whitney U for all comparisons).

There was a nonsignificant trend suggesting that receiving social support moderated the association between COVID-19 impact and depressive symptoms, p = .06, such that greater COVID-19 impact was associated with more depressive symptoms among adolescents reporting receiving low social support, p = .007, but not adolescents reporting average or high social support, p ≥ .13.

There was a nonsignificant trend to an increase in FCD throughout the study (10.9 (9.0–12.5) μm -1 at T0 vs 12.3 (11.3–14.0) μm -1 at T2; P = 0.06).

There was a nonsignificant trend in favour of surgery plus endocrine therapy (HR 0.86, 95% CI 0.73–1.00, P =0.06).

There was only a nonsignificant trend to explain effect size variation by actual prone duration ( z = -1.88; P = 0.06).

The prevalence of chronic kidney disease showed a nonsignificant trend toward a higher incidence in the PLF group (12.1% vs. 0%, p = 0.06).

When both the primary and secondary codes were pooled, there was also a nonsignificant trend ( P =0.06) for an increase in the presence of comments coded as Attitudes and Behaviors.

Cluster 2 exhibited a nonsignificant trend toward higher performance (73.8% vs 70.2%; 1-sided P =.06).

A comparison of gut microbial composition based on the education of parents showed that a higher education status of parents was associated with a nonsignificant trend toward an increase in microbial diversity as measured by the Shannon index ( P = .06) ( Figure 5b ).

Among the overall study cohort, there was a nonsignificant trend toward a greater incidence of sarcopenia in nonobese patients than in patients with obesity (54.1% vs. 42.1%; P = 0.06).

A nonsignificant trend suggested men rated nurse recommendations more positively than women ( χ 2 4 =5.54; P =.06), and younger adults rated overall program usefulness slightly higher ( χ 2 2 =4.87; P =.09).

Serratia significantly reduced bee survival ( χ 2 = 10.84, p < 0.001), and there was a nonsignificant trend for such effects to be stronger in the absence of the core gut microbiome ( χ 2 = 3.53, p = 0.060; Figure 5a ), although there was no detectable main effect of core microbiome treatment ( χ 2 = 0.41, p = 0.503; Figure 5a ).

1C ) and a nonsignificant trend to lengthening with Sham (from Base Sham = 265.2 ± 10.7 msec to Post Sham = 277.7 ± 11.6 msec, p = 0.06).

The physics forceps group showed a nonsignificant trend toward lower anxiety at baseline ( t 0 ; p = 0.060) and a significant reduction during extraction ( t 2 ; p = 0.001), whereas no significant difference was observed after anesthesia administration ( t 1 ; p = 0.450).

However, in a subgroup of patients with a TG level in the upper third (≥204 mg/dL [≥2.30 mmol/L]) and an HDL-C level in the lower third (≤34 mg/dL [≤0.88 mmol/L]), there was a nonsignificant trend ( P =0.06) for reduction in cardiovascular risk. 84 Niacin Prescription strength niacin is indicated to reduce elevated total cholesterol, LDL-C, apoB, and TG levels and to increase HDL-C in patients with primary hyperlipidemia, severe hypertriglyceridemia, and mixed dyslipidemia.

23 Initial meta-analysis incorporating all four studies showed a nonsignificant trend toward increased pneumonitis risk with poorer ECOG PS (HR = 1.37, 95% CI = 0.98–1.91, p = 0.06) ( Figure 10 A).

pyrrithrix : X 2 = 4.99, P = 0.026), and there was a nonsignificant trend in the same direction for H . hallani ( H . hallani : X 2 = 3.53, P = 0.060).

Sensitivity analyses showed similar results using random-effects model and mortality during all-time period as primary endpoint: increased mortality with low-intensity alerts (RR 1.15; 95% CI 1.00–1.32; I 2 = 0%; P = 0.04), decreased mortality with moderate-intensity alerts (RR 0.93; 95% CI 0.90–0.97; I 2 = 0%), and a nonsignificant trend in the high-intensity group (RR 0.92; 95% CI 0.85–1.00; I 2 = 49%; P = 0.06) (Additional file 1 : Supplementary Figs. 26, 27).

There was a nonsignificant trend across weeks 1 and 6 toward greater glucose variability before 1200 in the breakfast group compared with the fasting group (treatment effect: F = 3.9, P = 0.06).

There was a nonsignificant trend towards an association between peroneal CMAP amplitude and duration since symptom onset ( P = 0.06).

Evaluation of BALF revealed no significant difference in WBCs and total protein, although there was a nonsignificant trend toward lower WBCs in Cre + mice at day 21 ( P = 0.06; Fig. 3, B and C ).

Similarly, an increased number of risk alleles had a nonsignificant trend toward increased insulin sensitivity as assessed by the hyperinsulinemic-euglycemic clamp ( P = 0.06).

Moreover, we observed a nonsignificant trend in the same direction in segment 2 ( p = .06).

A nonsignificant trend was noted for the trained-side average AROM, (F(2,6) = 4.673, p = 0.060, η2=0.609) suggesting a potential benefit of MPWO over TOT for that measure.